Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.10.0.1
Consolidated Balance Sheets - USD ($)
$ in Millions
Jun. 30, 2018
Dec. 31, 2017
Current assets    
Cash and cash equivalents $ 874 $ 722
Restricted cash 2,386 1,880
Accounts and other receivables 278 369
Accounts receivable—related party 2 2
Inventory 233 243
Derivative assets 37 57
Other current assets 156 96
Total current assets 3,966 3,369
Non-current restricted cash 11 11
Property, plant and equipment, net 25,760 23,978
Debt issuance costs, net 97 149
Non-current derivative assets 107 34
Goodwill 77 77
Other non-current assets, net 309 288
Total assets 30,327 27,906
Current liabilities    
Accounts payable 29 25
Accrued liabilities 1,382 1,078
Current debt 137 0
Deferred revenue 99 111
Derivative liabilities 81 37
Total current liabilities 1,728 1,251
Long-term debt, net 26,782 25,336
Non-current deferred revenue 0 1
Non-current derivative liabilities 24 19
Other non-current liabilities 59 59
Commitments and contingencies (see Note 15)
Stockholders’ equity    
Preferred stock, $0.0001 par value, 5.0 million shares authorized, none issued 0 0
Outstanding: 248.1 million shares and 237.6 million shares at June 30, 2018 and December 31, 2017, respectively 1 1
Treasury stock: 12.6 million shares and 12.5 million shares at June 30, 2018 and December 31, 2017, respectively, at cost (394) (386)
Additional paid-in-capital 3,664 3,248
Accumulated deficit (4,288) (4,627)
Total stockholders’ deficit (1,017) (1,764)
Non-controlling interest 2,751 3,004
Total equity 1,734 1,240
Total liabilities and equity $ 30,327 $ 27,906